Red Queen Therapeutics, Inc. — Form D
Red Queen Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-02. The offering totals $55.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-11-02
- Form: D
- Accession: 0001891669-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $55.0M
- Amount sold: $5.0M
- Remaining: $50.0M
- Investors: 1
- Date of first sale: 2021-10-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-419494
Issuer
- Name: Red Queen Therapeutics, Inc.
- CIK: 0001891669
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 245 MAIN STREET, CAMBRIDGE, MA, 02142
- Phone: 203-232-7865
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Paul Da Silva Jardine | Director | New York, NY |
| Seth Harrison | Director | Redwood City, CA |
| Spiros Liras | Director | New York, NY |
| Loren Walensky | Director | Cambridge, MA |
| Paul Da Silva Jardine | Executive Officer | New York, NY |
More